Renal Cell Carcinoma clinical trials
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 1
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 1
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 1/2
- Phase
- Phase 1
Access comprehensive clinical trial information for Renal Cell Carcinoma through Pure Global AI's free database. This collection includes 293 clinical trials across multiple phases including N/A, Phase 2, Early Phase 1. Currently, 48 trials are actively recruiting participants.
Research for Renal Cell Carcinoma is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include Pfizer and Bristol-Myers Squibb. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 293 clinical trials studying Renal Cell Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Pfizer, Bristol-Myers Squibb, M.D. Anderson Cancer Center, among others.